Tag: Therapeutic Goods Administration

September 1, 2020

Aussie HVAC&R company makes COVID-19 advance

Australian IAQ, deep clean and corrosion protection expert Aeris Environmental has secured extended residual claims from the Therapeutic Goods Administration for its Aeris Active disinfectant cleaner. The on-label claims now include “Residual COVID-19 kill for up to seven days” and “Residual antibacterial for up to 30 days (or 200 touches) against gram-negative E. coli and […]